Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

IMAC Holdings Inc Stock Research

IMAC

Market Closed
Watchlist

IMAC Stock Price

IMAC RSI Chart

IMAC Valuation

IMAC Price/Sales (Trailing)

IMAC Profitability

EBT Margin

-132.25%

Return on Equity

-1.9K%

Return on Assets

-323.07%

IMAC Fundamentals

IMAC Revenue

Revenue (TTM)

6.9M

Revenue Y/Y

-73.3%

Revenue Q/Q

-35.8%

IMAC Earnings

Earnings (TTM)

-18.4M

Earnings Y/Y

23.9%

Earnings Q/Q

62.06%

Price Action

IMAC Financial Health

Current Ratio

0.51

IMAC Investor Care

Shares Dilution (1Y)

24.17%

Diluted EPS (TTM)

-0.16

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for IMAC

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-10-15
Evans Maurice E.
acquired
-
-
100,000
-
2022-10-15
Sucoff Cary
acquired
-
-
100,000
-
2022-10-15
Pruitt Michael D
acquired
-
-
100,000
-
2022-10-15
Pruitt Michael D
sold (taxes)
-11,507
0.311
-37,000
-
2022-05-21
Ervin Jeffrey S
acquired
-
-
37,500
chief executive officer
2022-05-21
Gardzina Sheri
acquired
-
-
9,375
chief financial officer
2022-02-21
Lerner Benjamin S
acquired
-
-
100,000
chief operating officer
2022-01-01
Sucoff Cary
acquired
-
-
50,000
-
2022-01-01
Evans Maurice E.
acquired
-
-
50,000
-
2022-01-01
Pruitt Michael D
acquired
-
-
50,000
-

1–10 of 43

Which funds bought or sold IMAC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-08-21
OSAIC HOLDINGS, INC.
unchanged
-
-5.00
18.00
-%
2023-08-21
OSAIC HOLDINGS, INC.
unchanged
-
-30,060
100,199
-%
2023-08-15
WELLS FARGO & COMPANY/MN
added
4.15
-6.00
22.00
-%
2023-08-15
GOLDMAN SACHS GROUP INC
sold off
-100
-2,049
-
-%
2023-08-15
MONETA GROUP INVESTMENT ADVISORS LLC
reduced
-0.04
-344
1,145
-%
2023-08-14
GUARDIAN WEALTH ADVISORS, LLC / NC
unchanged
-
-495
1,650
-%
2023-08-14
Tower Research Capital LLC (TRC)
reduced
-0.88
-809
1,191
-%
2023-08-14
Nantahala Capital Management, LLC
reduced
-94.82
-142,800
5,931
-%
2023-08-14
CLEAR STREET LLC
reduced
-50.00
-
-
-%
2023-08-14
VANGUARD GROUP INC
reduced
-68.09
-21,175
6,889
-%

1–10 of 35

Latest Funds Activity

Are funds buying IMAC calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own IMAC
No. of Funds

Schedule 13G FIlings of IMAC Holdings

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 07, 2023
alpha capital anstalt
4.99%
1,634,462
SC 13G/A
Jan 23, 2023
lynch peter s
4.24%
1,387,458
SC 13G
Sep 09, 2022
nantahala capital management, llc
3.8%
1,233,546
SC 13G/A
May 18, 2022
lynch peter s
5.23%
1,385,941
SC 13G
Feb 14, 2022
nantahala capital management, llc
9.1%
2,392,094
SC 13G/A
Jan 19, 2022
alpha capital anstalt
474%
1,958,871
SC 13G/A
Apr 12, 2021
nantahala capital management, llc
9.9%
2,500,000
SC 13G
Mar 24, 2021
alpha capital anstalt
9.58%
2,300,000
SC 13G
Feb 13, 2020
edward s. bredniak exempt trust
8.2%
699,409
SC 13G
Feb 13, 2020
edward s. bredniak 2008 grantor retained annuity trust
8.2%
699,409
SC 13G

Recent SEC filings of IMAC Holdings

View All Filings
Date Filed Form Type Document
Sep 08, 2023
8-K
Current Report
Aug 21, 2023
10-Q
Quarterly Report
Aug 14, 2023
NT 10-Q
NT 10-Q
Aug 04, 2023
8-K
Current Report
Jul 28, 2023
8-K
Current Report
Jul 06, 2023
8-K
Current Report

Peers (Alternatives to IMAC Holdings)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
69.4B
61.9B
-7.50% 26.00%
12.02
1.12
3.02% -11.37%
18.2B
14.1B
-4.84% -6.54%
21.91
1.29
-5.68% -58.27%
14.0B
9.5B
-5.93% 1.08%
17.63
1.48
-10.34% -46.50%
MID-CAP
9.4B
11.7B
1.41% 13.03%
20.16
0.8
0.96% -43.93%
9.0B
13.8B
0.58% 34.23%
13.07
0.66
5.76% -10.75%
7.8B
2.2B
2.63% 10.06%
34.39
3.56
2.13% -18.31%
7.1B
19.9B
-2.85% 22.41%
6.26
0.36
3.98% -22.32%
6.5B
2.8B
-6.23% -13.68%
23.9
2.33
13.40% -2.45%
3.3B
957.5M
-8.01% -15.46%
66.71
3.43
55.17% 8.05%
3.2B
4.4B
-5.70% -21.20%
10.02
0.73
-16.06% -30.43%
SMALL-CAP
274.6M
156.1M
-11.18% 22.01%
37.41
1.76
23.12% -14.70%
4.7M
10.8M
-41.82% -73.41%
-0.13
0.43
-71.53% 35.85%
-
6.9M
- -
-
-
-59.04% -71.13%

IMAC Holdings News

Digital Journal
EEG Disposable Medical Electrodes Market Size – Segmented by ....
Digital Journal,
44 hours ago
Becker's Orthopedic & Spine
Spine Review.
Becker's Orthopedic & Spine,
6 days ago
Clayton County Register
Clayton County Register
Halliburton: A Promising Investment Opportunity.
Clayton County Register,
31 days ago
Clayton County Register
Seeking Alpha

Returns for IMAC

Cumulative Returns on IMAC

Risks for IMAC

What is the probability of a big loss on IMAC?

null%


Probability that IMAC Holdings stock will be more than 20% underwater in next one year

null%


Probability that IMAC Holdings stock will be more than 30% underwater in next one year.

null%


Probability that IMAC Holdings stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does IMAC drawdown profile look like?

Y-axis is the maximum loss one would have experienced if IMAC Holdings was unfortunately bought at previous high price.

Drawdowns

Financials for IMAC Holdings

Income Statement (Last 12 Months)
Income Statement (Last 12 Months)
Description(%) Q/Q2023Q22023Q12022Q42022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q22018Q1
Revenue-51.8%6,874,67414,252,90016,185,68216,784,13515,216,56214,385,82813,480,48513,470,83012,577,89512,835,19813,615,51614,493,57915,677,75415,126,02614,155,36812,325,0989,203,0466,701,0715,222,3103,743,5482,264,787
Operating Expenses-12.4%29,106,39533,215,71534,465,97427,366,56426,410,59024,484,18622,258,40520,769,61719,173,38719,371,49119,718,23720,926,03022,512,70521,311,65720,086,83117,831,30913,515,10310,252,4676,762,0963,484,6392,576,172
  S&GA Expenses-13.9%5,999,8226,971,1057,281,4737,215,4497,018,7276,422,8185,634,0254,992,4904,539,7544,556,5544,752,0475,101,8415,323,2065,064,4374,800,9494,493,6303,800,9473,063,2702,203,1271,311,130765,321
EBITDA100.0%--17,467,144-16,672,001-8,899,281-9,469,236-8,388,957-5,361,443-3,928,568-3,344,399-3,256,906-4,327,461-4,641,651-4,969,413-5,140,135-5,374,675------
EBITDA Margin100.0%--1.23-1.03-0.50-0.62-0.58-0.40-0.29-0.27-0.25-0.32-0.32-0.32-0.34-0.38------
Interest Expenses140.7%30,15212,52714,191210,460331,955504,103621,348654,449663,142563,067420,739353,779304,068258,535242,069213,425160,943153,824107,18769,19148,617
Earnings Before Taxes2.3%-18,408,542-18,849,334-18,312,806-10,780,307-11,474,949-10,542,247-7,685,573-6,265,341-5,701,712-5,542,438-6,530,425-6,769,939-6,991,328-6,951,589-6,827,950-6,371,968-5,125,428-3,784,873-3,162,081-2,060,172-1,480,281
EBT Margin100.0%--1.32-1.13-0.60-0.75-0.73-0.57-0.47-0.45-0.43-0.48-0.47-0.45-0.46-0.48------
Net Income2.3%-18,448,391-18,889,183-18,312,806-10,780,307-11,474,949-10,542,247-7,685,573-6,265,341-5,701,712-5,542,438-6,965,973-7,042,536-7,263,925-6,497,230-6,713,332-6,144,038-4,897,497-3,053,743-2,739,701-1,739,600-1,052,853
Net Income Margin100.0%--1.32-1.13-0.60-0.75-0.73-0.58-0.47-0.42-0.39-0.49-0.47-0.42-0.43-0.42------
Free Cashflow100.0%--9,232,738-10,625,850-9,900,679-9,140,835-8,294,376-8,159,373-7,695,379-6,770,594-6,119,373-5,858,348-6,195,990-5,496,834-5,268,959-2,852,584------
Balance Sheet
(In Thousands)
Balance Sheet
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets-20.5%4,6455,84311,08218,53222,06824,20027,22929,16432,53233,62819,74619,37421,86121,10420,41821,01722,40917,99011,07511,45410,922
  Current Assets-29.2%1,2761,8024,2086,4845,3726,6789,06813,54616,26318,2994,7573,7924,8933,5412,5782,1634,0224,1326681,3531,217
    Cash Equivalents-36.7%2473907632,8331,6144,2757,11911,19413,62215,6082,6241,6642,8031,2823747412,2313,066194242213
  Net PPE-17.2%5666831,5851,7672,0502,2852,3231,7771,8691,8311,7771,8623,2943,5313,6924,0053,5893,2213,3343,4203,446
  Goodwill----4,5004,6624,6624,6622,0412,0412,0412,0412,0412,0412,0412,0412,0422,0422,0422,042--
Liabilities3.3%5,0044,8466,4306,9777,9739,2289,2769,63910,15410,79511,93312,88213,93713,82112,48113,25513,12110,90415,00714,49712,710
  Current Liabilities11.1%3,9243,5323,7143,8544,5635,2384,9345,3665,4386,6015,9506,0418,7719,2856,0665,9316,1506,50213,83113,24511,081
Shareholder's Equity-136.0%-3589974,65111,55514,09514,97217,95319,52522,37822,8337,8136,4927,9247,2837,9377,7629,2877,086---
  Retained Earnings-2.8%-51,621-50,218-46,519-39,546-33,213-31,369-28,206-25,325-22,432-19,894-17,664-17,639-16,167-14,192-12,122-8,593-7,044-5,144-3,544-2,607-1,627
  Additional Paid-In Capital0.1%51,22951,18251,13851,06947,28146,31546,13444,82544,78642,70325,46524,12024,08021,46520,05118,86318,67714,2801,2341,2321,232
Shares Outstanding0.8%33,28033,01732,93532,50326,80126,36626,21825,32225,14313,44912,74710,5509,8989,6118,9138,3668,1065,9204,5344,5344,534
Minority Interest---------4,572-3,400-2,858-2,618-2,403-2,361-2,416-2,080-2,515-2,352-2,057-1,625-1,674-1,398
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Last 12 Months)
(In Thousands)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations33.1%-6,101-9,119-10,294-10,070-9,123-8,433-7,590-7,714-7,338-6,586-5,993-5,293-5,374-4,331-4,068-2,990-2,756-2,125-1,808-1,913-916
  Share Based Compensation-10.4%30634144535345850057150342342239241542047039229218315.0015.0022.0025.00
Cashflow From Investing11.7%1,1241,006-259-1,517-1,675-1,990-2,457-1,229-1,152-1,045-569-861-1,117-1,217-1,053-233308-330-1,603-2,089-2,481
Cashflow From Financing-14.6%3,6114,2284,1993,227-1,209-90814,54318,47319,31021,9578,8137,0787,0643,7665,3013,7234,4684,9713,4793,9273,323

IMAC Income Statement

2023-06-30
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Patient revenues, net$ 1,343,975$ 5,033,088$ 3,437,337$ 8,928,075
Total revenue1,343,9755,033,0883,437,3378,928,075
Operating expenses:    
Patient expenses175,748397,235441,980857,708
Salaries and benefits1,251,8423,863,0893,564,9037,762,487
Advertising and marketing36,761242,562111,305613,050
General and administrative886,6321,857,9152,391,5063,673,162
Depreciation and amortization119,795438,612309,618885,384
Loss on disposal or impairment of assets254,14734,8321,695,16182,261
Total operating expenses2,724,9256,834,2458,514,47313,874,052
Operating loss(1,380,950)(1,801,157)(5,077,136)(4,945,977)
Other income (expense):    
Interest income11,32111,321
Other expense(39,530)(52,704)
Interest expense(22,358)(4,733)(24,825)(8,864)
Total other expenses(22,357)(42,942)(24,824)(60,247)
Net loss before income taxes(1,403,307)(1,844,099)(5,101,960)(5,006,224)
Income taxes
Net loss$ (1,403,307)$ (1,844,099)$ (5,101,960)$ (5,006,224)
Net loss per share attributable to common stockholders    
Net loss per share attributable to common stockholders basic$ (0.04)$ (0.07)$ (0.15)$ (0.19)
Net loss per share attributable to common stockholders, diluted$ (0.04)$ (0.07)$ (0.15)$ (0.19)
Weighted average common shares outstanding    
Weighted average common shares outstanding, basic33,141,32426,800,92633,077,59826,584,532
Weighted average common shares outstanding, diluted33,141,32426,800,92633,077,59826,584,532

IMAC Balance Sheet

2023-06-30
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current assets:  
Cash$ 247,002$ 763,211
Accounts receivable, net678,6032,881,239
Deferred compensation, current portion102,153196,119
Other assets248,578367,358
Total current assets1,276,3364,207,927
Property and equipment, net565,8431,584,714
Other assets:  
Intangible assets, net901,8931,365,457
Security deposits215,126300,430
Right of use asset1,685,8023,623,078
Total other assets2,802,8215,288,965
Total assets4,645,00011,081,606
Current liabilities:  
Accounts payable and accrued expenses2,441,2611,702,740
Patient deposits186,139241,666
Notes payable, current portion39,43551,657
Finance lease obligation, current portion16,85319,898
Liability to issue common stock, current portion292,246329,855
Operating lease liability, current portion947,6571,368,016
Total current liabilities3,923,5913,713,832
Long-term liabilities:  
Notes payable, net of current portion35,14453,039
Finance lease obligation, net of current portion2,5809,375
Operating lease liability, net of current portion1,042,6552,654,104
Total liabilities5,003,9706,430,350
Commitment and Contingencies – Note 14
Stockholders’ equity (deficit):  
Preferred stock - $0.001 par value, 5,000,000 authorized, nil issued and outstanding at June 30, 2023 and December 31, 2022, respectively.
Common stock - $0.001 par value, 60,000,000 authorized; 33,280,758 and 33,017,758 shares issued at June 30, 2023 and December 31, 2022, respectively; and 33,280,049 and 32,935,294 outstanding at June 30, 2023 and December 31, 2022, respectively.33,28032,935
Additional paid-in capital51,229,45051,138,061
Accumulated deficit(51,621,700)(46,519,740)
Total stockholders’ equity (deficit)(358,970)4,651,256
Total liabilities and stockholders’ equity (deficit)$ 4,645,000$ 11,081,606
Jeffrey S. Ervin
180
IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company operates 17 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is based in Brentwood, Tennessee.